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Abstract
Background The receptor for formylated peptides, formyl
peptide receptor 1 (FPR1), potently activates and serves as
a chemoattractant receptor for neutrophils.
Aim Given the abundance of neutrophils in the inﬂamed
colon, our aim was to determine if the FPR1 mediates
colonic neutrophil migration, using the dextran sodium
sulfate (DDS)-induced model of colitis.
Methods Formyl peptide receptor 1 gene-deﬁcient mice
were administered DDS in drinking water for a single
5-day period (acute) or in two 5-day periods separated by
16 days (chronic). At the end of the treatment their colons
were excised, measured, and prepared for histological
evaluation.
Results FPR1
-/- mice experienced less severe acute colo-
nic pathology than C57BL/6 (wildtype) mice. The opposite
was observed following the second colitis cycle, with
FPR1
-/- mice developing worse pathology than wildtype
mice. Both strains had similar numbers of inﬁltrating
neutrophils in ulcerated areas of the colon after a single DSS
cycle, but FPR1
-/- mice had signiﬁcantly more neutrophils
in the ulcerated mucosa after two cycles. There was no dif-
ference in the capacity of neutrophils from each strain to
migrate to chemoattractants. Since the FPR1
-/- mice had
larger ulcers compared to the wildtype mice, we propose that
the FPR1
-/- mice failed to recover at the same rate as
wildtype mice. This apparent difference in restitution could
not be attributed to observable differences in annexin A1.
Conclusions We conclude that neutrophil migration into
the inﬂamed mouse colon does not depend on FPR1 but
that FPR1 contributes in other pathological mechanisms
that are harmful during acute inﬂammation but protective
during chronic inﬂammation.
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Introduction
Bacterial protein translation is initiated with N-formyl
methionine, which in many proteins is cleaved post-trans-
lationally, resulting in the release of low-molecular-weight
formylated peptides, including those by bacteria from the
intestines [1]. Mammalian cells detect formylated peptides
with a family of seven membrane-spanning G-protein
coupled receptors, the principal one being formyl pep-
tide receptor 1 (FPR1). This innate immune receptor was
ﬁrst described on neutrophils that were found to become
activated by binding the prototypic formyl peptide, N-for-
myl-methionyl-phenylalanine (fMLF) [2–4]. Given the
abundance of bacteria in the colon, there is good reason to
believe that formyl peptides play a role in recruiting neu-
trophils into intestinal inﬂammatory diseases.
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whether these contribute to gastrointestinal inﬂammation
has not been directly shown. Instead, researchers have
applied fMLF to the rodent intestinal lumen, with mixed
outcomes. In one example, fMLF applied in a small
intestinal perfusate resulted in increased microvascular
permeability, yet had no effect on neutrophil numbers
[5, 6]. In a second example, the fMLF resulted in marked
neutrophil inﬁltration in the perfused segment [7]. Other
researchers have added fMLF to rats experiencing experi-
mentally induced colitis, thereby exacerbating the colitis
[5, 8]. Exacerbated experimental colitis may indicate that a
breach of the epithelium must ﬁrst occur to permit effective
diffusion of the peptide into the mucosa. However, the
ﬁnding of increased neutrophil numbers when fMLF is
applied to the healthy rodent colon is inconsistent, and in
none of these studies was it assessed whether endogenous
levels of formyl peptides act to recruit neutrophils using
FPR1.
Another approach to address the question of which
chemoattractants may be active is to use mice deﬁcient for
chemoattractant receptors. We and others have previously
used mice deﬁcient for the chemokine receptor CXCR2 to
gain insights into the role this receptor plays in neutrophil
recruitment into the colon [9, 10]. The CXCR2 gene
knockout strain had reduced numbers—but not the abla-
tion—of neutrophils in the mucosa of the dextran sodium
sulfate (DSS) inﬂamed colon, leading to the conclusion that
this family of chemokine ligands does not work alone. In
light of evidence that exogenous fMLF enhances colonic
neutrophil inﬁltration during induced colitis and that the
neutrophils of patients with inﬂammatory bowel disease
possess increased numbers of FPR1 [11], we thought it
interesting to examine FPR1 gene-deﬁcient mice with
DSS-induced colitis. We report here that the gene deﬁ-
ciency has little impact on neutrophil numbers inﬁltrating
the acutely inﬂamed colon, but it does result in heightened
numbers of cells inﬁltrating the chronically inﬂamed colon,
which is associated with more severe disease.
Materials and Methods
Animals
Formyl peptide receptor 1 gene-deﬁcient mice on the
C57BL/6 genetic background were kindly provided by Dr.
P. Murphy (NIAID, National Institutes of Health,
Bethesda, MD) [12]. The strain was bred in our facility and
on two occasions over 24 months were bred with C57BL/6
mice (Charles River Laboratories, Saint-Constant, QC,
Canada), then back to homozygosity for the knockout gene.
C57BL/6 mice served as wildtype controls. All animal
experiments were approved by the Dalhousie University
Committee on Laboratory Animals, which adjudicates the
guidelines of the Canadian Council on Animal Care.
DSS Colitis and Clinical Scoring
To induce acute colitis, we added 4% DSS
(36,000–50,000 MW; MP Biomedicals, Solon, OH) to the
animals’ water for 5 days, followed by facility water until
the ninth day when they were euthanized. For the chronic
studies, mice received 4% DSS for 5 days, followed by
facility water until day 22, after which they were once
again given 3% DSS for 5 days; they were euthanized on
day 34. Mice were weighed throughout the experiment, and
the consistency of their stool and whether blood was
present in their stool were recorded (Hemoccult kit;
Beckman-Coulter, Mississauga, ON, Canada).
Pathology Scores and Explant Cultures
At the end of the experiments, mice were euthanized by
CO2 asphyxiation and their colons removed and the length
measured. The colons were opened longitudinally along the
mesenteric axis, bisected longitudinally, and one half was
prepared in a Swiss roll and ﬁxed in buffered formalin. The
ﬁxed tissue was prepared in parafﬁn and 3-lm-thick sec-
tions were cut and stained using hematoxylin and eosin.
The stained sections were assessed for pathology by two
blinded researchers using a scale that takes into account the
presence (or not) of submucosal edema, the extent of
mucosal ulceration, crypt loss, and inﬁltration (for a more
detailed description of the scale, see [10]). The second half
of the dissected colon was weighed, then washed repeat-
edly in RPMI media with antibiotics (50 U/ml penicillin
and 50 lg/ml streptomycin; Life Technologies, Burlington,
ON, Canada) and incubated in media containing antibiotics
and 10% fetal calf serum. The supernatants were recovered
after 24 h and stored frozen until assayed for macrophage
inﬂammatory protein 2 (MIP-2) using an enzyme-linked
immunosorbent asssay (ELISA; PeproTech Canada, Dol-
lard des Ormeaux, QC, Canada). The results were expres-
sed as: [total MIP-2 divided by the weight of the colon
(mg)] 9 100.
Immunohistochemistry
Mouse colon sections were de-parafﬁnized, and antigen
retrieval was performed in sodium citrate buffer. Endoge-
nous peroxidases were ﬁrst blocked using 3% H2O2, fol-
lowed by blocking the sections using 5% goat serum–
phosphate buffered saline (PBS)/Tween. The sections were
incubated with rat anti-mouse Ly6G (BD Biosciences, San
Jose, CA) or anti-annexin A1 (Santa Cruz Biotechnology,
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washed and incubated with biotin conjugated goat anti-rat
antiserum (Santa Cruz Biotechnology) for 1 h at room
temperature, followed by further washes. Avidin–biotin
complex (Vector Laboratories, Burlingame, CA) was
added for 30 min at room temperature, following which the
sections were incubated with 3,3-diaminobenzidine
(Amersham Biosciences, Piscataway, NJ) for 10 min at
room temperature, washed, counterstained with Mayer’s
hematoxylin, and processed for mounting.
Ex vivo Neutrophils Migration Assay
Neutrophils recovered from the ﬁbia and tibia of mice were
used in Transwell migration assays essentially as described
elsewhere for human cells [13]. Brieﬂy, bone marrow were
enriched using Percoll gradients and radiolabeled with
Na2
51CrO4 (Amersham, Oakville, ON, Canada); 10
5 cells
were then applied to the upper Transwell ﬁlter chamber
(pore size of ﬁlter 4 lm), with the chemoattractant in the
bottom chamber. After a 90-min incubation, the ﬁlter and
upper chamber were removed and the ﬁlter bottom washed
to remove any loosely adherent cells. These cells were
pooled with cells that had migrated into the bottom
chamber and all cells were lysed with 1% Triton X-100 and
the amount of radioactivity counted in an automatic gamma
counter (Wallac, Turku, Finland). The migrated fraction of
neutrophils was expressed as a percentage of the total input
number of neutrophils.
Western Blotting
The entire colon was cut open longitudinally and washed
twice with cold PBS. A 500-ll aliquot of lysis (M2) buffer
was added onto the mucosal side for 5 min, following
which the mucosa was scraped using a scalpel. The
recovered solution was transferred to a cold microfuge tube
and vortex shaken gently for 1 min. Protein concentrations
were determined (BioRad, Hercules, CA) before separation
by sodium dodecyl sulfate-polyacrylamide gel electropho-
resis (SDS-PAGE). Both cell lysates and protein standards
(Bio-Rad) were mixed with SDS sample buffer and
resolved by 7.5–10% SDS-PAGE. Following electropho-
resis, the proteins were electro-transferred onto nitrocel-
lulose membranes, and the ﬁlters were incubated with 5%
non-fat milk in TRIS buffered saline for 1 h and then
processed for immunolabeling. Membranes were probed
with a rabbit anti-mouse Annexin A1 antiserum (Santa
Cruz) overnight at 4C. b-actin probing was used as a
loading control. Horseradish peroxidase-labeled goat anti-
rabbit antiserum was used as the secondary reagent at room
temperature for 1 h. The immunoreactivity was visualized
with chemiluminescence (Amersham Pharmacia Biotech,
Buckinghamshire, UK) and subsequent exposure to X-ray
ﬁlm.
Statistical Analyses
Data were expressed as the mean ± standard error of the
mean (SEM). Differences in histopathologic scoring were
evaluated by the Mann–Whitney U test, while all other
measures were analyzed using the two-tailed Student’s
t test (SPSS ver. 14.0; SPSS, Chicago, IL). Statistical sig-
niﬁcance was set at a p value of B0.05.
Results
FPR1
-/- Mice Show Different Patterns of Weight Loss
Following One Versus Two DSS Cycles
During the ﬁrst cycle of DSS treatment a decrease in body
weight was observed in both strains of mice (Fig. 1). The
average maximum weight loss among C57BL/6 and
FPR1
-/- mice was 14 and 5%, respectively. The C57BL/6
mice developed diarrhea and gross blood in their stool,
while FPR1
-/- mice had soft stools with occult blood but
no diarrhea. The difference in weight loss between the
strains was signiﬁcant on days 6, 7, and 8. Three days after
the DSS treatment was discontinued, both strains began to
gain weight. By day 22, the C57BL/6 mice had gained
more weight than the FPR1
-/- mice (Fig. 1). During the
second DSS cycle the FPR1
-/- mice experienced a greater
weight loss than the C57BL/6 mice as well as more severe
bloody diarrhea, and they failed to gain weight after the
DSS was discontinued. The weight differences were sta-
tistically signiﬁcant between and including days 22–34
(Fig. 1).
Histopathology Following One DSS Cycle: FPR1
-/-
Mice Show Less Inﬂammation than C57BL/6 mice
Histological examination of the colons of C57BL/6 mice
administered 4% DSS revealed submucosal edema with
dilated blood vessels, ulceration, extensive mononuclear
cell and neutrophil inﬁltration, and the loss of crypts at
multiple sites of the mid-colon (Fig. 2a–c). In comparison,
histological examination of the FPR1
-/- colon showed
stretches with submucosal edema but with less ulceration,
inﬁltration, and crypt damage than in C57BL/6 mice
(Fig. 2d–f). The histopathology scores were statistically
signiﬁcantly different between the strains (Fig. 2g) as were
their colon lengths (Fig. 2h).
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-/- Mice Show
More Inﬂammation than C57BL/6
C57BL/6 mice showed less pathology at the end of the
experiments following the second DSS cycle than they did
after the ﬁrst cycle, including smaller scattered ulcers
(Fig. 3a, b). The large weight loss among FPR1
-/- mice
indicated that they might have worse colon histopathology,
and indeed these mice showed considerable submucosal
edema and mucosal ulceration with mononuclear and
neutrophil inﬁltration, including crypt abscesses, in multi-
ple sites affecting upwards of 75% of this stretch of colon
(Fig. 3d–f). The histopathology scores were signiﬁcantly
different (Fig. 3c), as were the colon lengths (not shown).
Inﬂamed FPR1
-/- Mice Exhibit Neutrophil Inﬁltration
of the Colon
Neutrophils are a hallmark inﬁltrating leukocyte in the
DSS-induced inﬂamed colon. As we are interested in
knowing whether the FPR1 plays a role in the inﬂammation
process, we stained sections for Ly6G [14]. In our expe-
rience, some of the Ly6G
? cells in the inﬂamed mouse
colon are mononuclear, allowing these cells to be distin-
guished from PMN under high magniﬁcation. The healthy
mouse colon had only a few scattered Ly6G
?-positive cells
(not shown), but mucosal and submucosal inﬁltration
occurred in both strains following DSS treatment, with no
signiﬁcant difference between strains (Fig. 4a–c). After the
second DSS cycle, both strains again showed high numbers
of Ly6G
? PMN, but the FPR1
-/- mice had signiﬁcantly
greater numbers than the C567BL/6 mice (Fig. 4d–f). Both
strains had similar numbers of inﬁltrating Ly6G
? mono-
nuclear cells (Fig. 4c, f).
Strain Differences in Neutrophil Inﬁltration Are Not
Due to Intrinsic Differences in the Response
to Chemoattractants
We were interested in determining whether the increase in
neutrophil inﬁltration may be due to an intrinsic difference
(increase) in the chemotactic response by neutrophils from
FPR1
-/-mice,particularlyaftertheﬁrstcycleofDSS.Bone
marrow cells were isolated from mice 22 days after the start
of the ﬁrst DSS cycle, e.g., on the same day that the second
DSS cycle was started (Fig. 1). The neutrophils were enri-
ched on Percoll density gradients to 95% purity, following
which the cells were radiolabeled and applied to the top of a
Transwell ﬁlter chamber. Migration of the cells through the
ﬁlter into the bottom chamber was then induced by placing a
chemoattractant in the bottom chamber. Figure 5a shows
that both C5a (protein fragment from complement compo-
nent C5) and MIP-2 recruited neutrophils from both strains,
without any difference in potency, leading us to conclude no
obvious alteration had occurred in the neutrophils from
inﬂamed FPR1
-/- mice that might explain their heightened
Fig. 1 Pattern of weight changes in C57BL/6 and formyl peptide
receptor 1-deﬁcient (FPR1
-/-) mice receiving one (acute) or two
(chronic) cycles of dextran sodium sulfate (DSS) in their drinking
water. Data are presented as the mean and standard error of the mean
(SEM) of their percentage weight relative to the each respective
animal’s starting weight. n = 8 mice of each strain, conducted in two
experiments. Asterisk indicates a statistically signiﬁcant difference
between strains
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inﬂamed mice we recovered the colon and, following
extensive washes in antibiotic-containing media, cultured
the tissue overnight in order to recover the secreted
chemoattractants. The MIP-2 concentrations in these
supernatants are shown in Fig. 5b. MIP-2 concentrations of
healthy mouse colons were\3.5 ng/ml, essentially off the
scale of units in Fig. 5b. In contrast, MIP-2 levels were
Fig. 2 Representative images
showing colon histopathology
of acutely inﬂamed mice
sacriﬁced on study day 9. a, b,
c Increasing magniﬁcations of
the same section from a C57BL/
6 mouse, d, e, f increasing
magniﬁcations of the same
section from a FPR1
-/- mouse.
g The average for each element
in the histopathological
(inﬂammation) score for the two
strains. The difference between
the sums of each mouse strain’s
pathology scores in g is
statistically different by Mann–
Whitney U test. h Colon
lengths. Differences in colon
lengths between the two strains
were statistically signiﬁcant
(p\0.05) according to
Student’s t test (asterisk). In
g and h, n = 8 mice of each
strain. Bars Mean and SEM
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pared to their healthy controls. However, despite the
appearance of higher MIP-2 concentrations in FPR1
-/-
mice, there was no statistically signiﬁcant difference
between the inﬂamed strains.
Inﬂamed FPR1
-/- Mice Show Severe Ulcers
yet Wound Healing Proceeds
In a further characterization of the differences between
C57BL/6 and FPR1
-/- colons, we observed that following
the second DSS treatment stretches of the mucosa with
crypt loss in the C57BL/6 mice were completely or near
completely re-epithelialized (Fig. 6a, b). Contrasting this,
and with the exception of small ulcers, most ulcers in
FPR1
-/- mice were incompletely re-epithelialized
(Fig. 6c–e). Measurements of the ulcers demonstrated that
on average the ulcers were longer (larger) in FPR1
-/- mice
than in C57BL/6 mice (Fig. 6f).
Mucosal Annexin A1 Levels Are Similar Between
the Two Strains of DSS-Inﬂamed Mice
FormylpeptidesactingthroughFPR1onneutrophilspromote
inﬂammation by recruiting cells and causing degranulation,
but FPR1 can be anti-inﬂammatory when annexin A1 binds
and inhibits neutrophil extravasation [15]. Annexin A1 can
also directly regulate the recovery from intestinal mucosal
Fig. 3 Representative images
showing the colon
histopathology of chronically
inﬂamed mice sacriﬁced on
study day 34. a, b C57BL/6
mice, d, e, f FPR1
-/- mice.
f Asterisk denotes leukocytes
in a crypt. c Histopathological
scoring for the two strains. Bars:
Mean and SEM of each element
of the pathology scale, with
n = 8. The difference between
the sums of each mouse strain’s
pathology scores in c is
statistically signiﬁcant at
p\0.05 according to the
Mann–Whitney U test
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123injury [16] and repair of the gastric mucosa [17]b ya c t i n go n
epithelial cells, which have recently been found to express
formyl peptide receptors. In this context, autocrine annexin
A1 acts through the FPRL1 to promote epithelial cell
migration. Our results showing the presence of copious
numbers of neutrophils and larger ulcers in FPR1
-/- mice
may be related to a reduction in these anti-inﬂammatory
activities of annexin A1, leading us to examine annexin A1
levels in the mice. Figure 7 shows that mucosal annexin A1
levels following a single DSS cycle were similar in the two
strains. Noteworthy, annexin A1 observed by immunohisto-
chemistry was reduced in both strains following the second
DSScycle(Fig. 7d–f)comparedtotheﬁrstcycle(Fig. 7a–c).
Hence, a strain-speciﬁc lack of annexin A1 expression is
unlikely to explain the exacerbation of ulcer formation or
reduced re-epithelialization in FPR1
-/-mice.
Discussion
The family of formyl peptide receptors comprises three
members, i.e., FPR1, FPRL1, and FPRL2. Of these, the
FPR1 of humans is considered to be the principal receptor
for fMLF. On neutrophils, FPR1 represents a potent
receptor, leading to cell activation and chemokinesis. In
actual fact, the migration of human neutrophils to fMLF
desensitizes other G-protein-coupled receptors involved in
chemotaxis; for example, the activation of FPR results in
the cross-desensitization of CXCR1 and CXCR2 [18].
Thus, it would seem likely that bacterial formyl peptides
would mediate neutrophil migration into the mucosa and
lumen via the FPR1 even if another chemoattractant ﬁrst
recruited the cells out of the blood. However, testing this
hypothesis in mice must take into consideration some of
the differences between the mouse versus human family of
receptors. In mice, the FPR gene family has at least eight
members, with FPR1 the mouse ortholog of human FPR1,
although the mouse receptor is approximately 100-fold less
sensitive to fMLF than the human receptor [4]. However,
the mouse receptor still binds formyl peptides, such as
fMIFL [19], and may, therefore, mediate migration to
formyl peptides derived from resident bacteria during
colitis. We sought to address this issue using FPR1 gene
knockout mice.
Fig. 4 Ly6G immunohistochemical staining identiﬁes neutrophils
(polymorphonuclear leukocytes, PMNs) in the inﬂamed colon
sections. Representative images showing colon histopathology on
day 9. a, d C57BL/6 mice, b, e FPR1
-/- mice. c The average Ly6G
?
cell count from mice killed on day 9. Ly6G
? cells with polymorphic
nuclei (neutrophils) and mononuclear cells were counted in the
mucosa versus submucosa throughout the entire colon on a single
section of each mouse of both strains. f The average Ly6G
? cell count
from mice killed on day 34. The difference between the number of
mucosal neutrophils in the chronically inﬂamed C57BL/6 versus
FPR1
-/- mice is statistically signiﬁcant at p\0.05 (asterisk)
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mice were shown to have increased susceptibility to Lis-
teria monocytogenes infection [12], although it was not
determined whether this was directly due to a failure to
respond to bacterial products or an indirect effect, such as
the loss of a host-derived factor that activated leukocytes
through FPR1. It was subsequently conﬁrmed that the
mouse receptor does directly respond to Listeria peptides
[19], thereby conﬁrming that the receptor is involved in the
host reaction to a pathogen. Additionally, mitochondria-
derived N-formylated peptides are also potent agonists for
FPR1 [20]. In this case and possibly in the mouse also,
mitochondrial formylated peptides may activate FPR1 on
neutrophils during host cell damage. All of these results
suggest that this receptor plays a role in promoting
inﬂammation. Using the FPR1
-/- strain, we speculated
that formyl peptides generated by bacteria or injured epi-
thelial cells would attract neutrophils into the mucosa and
lumen, therefore also contributing to inﬂammation. How-
ever, our data using the FPR1
-/- strain suggests that this
not the case. While the colonic pathology in acutely
inﬂamed FPR1
-/- mice was less than that in C57BL/6
mice, there was a similar number of inﬁltrating neutrophils
in the two strains. One explanation may be the relatively
late time at which our measurements were made after
discontinuing the DSS treatment. It is possible that the
kinetics of inﬁltrating neutrophils differed, for example, at
the time of maximal weight loss between days 7 and 8. Yet
both strains still had reduced body weights and inﬂamed
colons at the time the acute experiment was ended, indi-
cating that the mice were ill. Another consideration is a
possible indirect effect of formyl peptides acting through
FPR1, such as on parenchymal cells, to stimulate other
chemoattractants, such as leukotrienes [21]. However,
given the similar number of neutrophils that inﬁltrated the
colon in FPR1
-/- and C57BL/6 mice and the greater
number of neutrophils following two cycles of DSS, there
would seem to be no reduction in the chemotactic signals
due to the loss of the receptor. We conﬁrmed the latter
hypothesis by measuring MIP-2 levels, as a representative
CXC chemokine, secreted from the inﬂamed colons. This
family of chemotactic molecules plays a signiﬁcant role in
DSS colitis, and any reduction in levels would likely be
associated with reduced inﬂammation [9, 10]. DSS does
lead to a neutrophilia and it is possible that the FPR1
-/-
mice respond by mobilizing greater numbers of cells from
their bone marrow, but we did not evaluate this in the two
strains. We did assess whether neutrophils from inﬂamed
FPR1
-/-mice migrate more effectively to chemoattractants
than wildtype cells. Our results demonstrate this is not the
case as FPR1-deﬁcient neutrophils migrated to two che-
moattractants equally as effectively as neutrophils from
C57BL/6 mice. The sum of these ﬁndings leads us to
conclude that the FPR1 does not mediate neutrophil
recruitment, either directly or indirectly, into the DSS
inﬂamed colon.
The data lead us not only to this conclusion, but also to
the conclusion that the lack of FPR1 offers some protection
from DSS colitis in the acute setting independent of neu-
trophils. FPR1
-/- mice experienced less severe patholog-
ical changes than C57BL/6 mice despite both strains
having a similar number of inﬁltrating neutrophils. This
result could be explained by the neutrophils becoming
activated through the FPR1 and thus contributing to tissue
damage in the C57BL/6 mice; however, there are prece-
dents showing that acute DSS colitis occurs in neutrophil-
depleted (anti-Gr1 treated) mice [22] and in other models
of induced colitis [23]. If DSS colitis is neutrophil inde-
pendent, then the FPR1 must have roles in colon pathology
independent of neutrophils.
The C57BL/6 strain is relatively susceptible to DSS and
reportedly continues into a chronic inﬂammatory condition
following a single DSS cycle despite the mice recovering
from their weight loss [24]. The C57BL/6 mice in our study
recovered their body weight and the signs of chronic
inﬂammation were not apparent even after exposure to a
second DSS cycle. Most of the ulcers in these mice had
Fig. 5 Neutrophils from inﬂamed FPR1
-/- mice respond to chemo-
attractants in a similar manner as neutrophils from inﬂamed C57BL/6
mice. Neutrophils were enriched to 95% from the bone marrow of
both strains 22 days after starting a DSS cycle (acutely inﬂamed, as in
Fig. 1) a Neutrophils were tested for migration to 10
-8 M human
recombinant C5a (protein fragment of complement component C5)
and 10
-8 M recombinant macrophage inﬂammatory protein 2 (MIP-
2). Bars: Mean ± SD, n = 4 mice, one of two experiments
(conducted using mice sacriﬁced on day 21). b MIP-2 levels in
24 h ex vivo colon culture supernatants from the same mice as in
a (e.g., following one cycle of DSS). WT Wildtype (C57BL/6)
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contrast, the FPR1
-/-mice failed to recover their body
weight to the same extent as the C57BL/6 mice, suggesting
that they failed to fully recover from the ﬁrst episode of
DSS. With the heightened neutrophil inﬁltrate, it is possi-
ble that these cells contribute to the chronic injury despite
not contributing to the acute injury or the ﬁrst DSS cycle.
To the best of our knowledge there is no published report
on whether neutrophils contribute to the pathology of a
second exposure to DSS.
Examination of the FPR1
-/- mice colons revealed that
one obvious difference from those of the wildtype mice
was that the ulcers of the former were not entirely re-
epithelialized. We initially thought this was due to a failure
of restitution and started to examine annexin A1, a potent
mediator of restitution [16]. Annexin A1 levels increase
during DSS colitis, with the molecule acting through the
FPRL1 [16]; however, we speculated that mucosal levels of
annexin A1 might be upregulated by signals through the
FPR1 acting as a sensor for invasive bacteria. Furthermore,
Fig. 6 Colon sections from
chronically inﬂamed mice
showing the extent of restitution
or re-epithelialization of
ulcerated regions. a Epithelium
has entirely crowned the
damaged mucosa in this
example from a C57BL/6
mouse, identiﬁed by the
asterisk. b A higher
magniﬁcation image of the ulcer
margin taken from the image in
a. c An ulcer remains without
epithelium on a long stretch of
damaged mucosa in the
FPR1
-/- mouse. d Low-power
micrograph of a second
FPR1
-/- mouse colon showing
mixed extent of restitution;
asterisk denotes re-
epithelialized ulcers, dollar sign
non-epithelialized ulcers. e A
higher magniﬁcation example of
a completely re-epithelialized
region of damaged crypts in an
FPR1
-/- mouse. f Average
ulcer length in the two strains
reveals that ulcers are longer in
the FPR1
-/- mice, with the
difference statistically
signiﬁcantly different at
p\0.05 (asterisk)
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epithelium [25, 26] and to play a role in model epithelial
cell restitution [27], so the possibility exists that epithelial
annexin A1 could be upregulated through FPR1 in mice.
Our immunohistochemical detection of annexin A1 proved
otherwise, and there was no apparent difference between
strains. We complemented the immunohistochemistry with
Western blotting of inﬂamed colonic mucosal scrapings to
provide more quantitative data and again the levels
between the two strains were similar. It is noteworthy that
we detected low levels of annexin A1 in the mouse colon
after the second DSS cycle in both mouse strains. These
results mean that the lack of FPR1 is not responsible for the
apparent failure to replenish epithelial levels of annexin A1
following the second DSS cycle. The almost complete
re-epithelialization of the C57BL/6 colons suggests there
are sufﬁcient levels of endogenous factors for restitution,
including restitution in the presence of neutrophils and
after two DSS cycles.
Finally, in the absence of any obvious effect on annexin
levels,anotherexplanationforthechronicepithelialdamage
inFPR1
-/-micemayberelatedtoananti-inﬂammatoryrole
described for fMLF in which fMLF acts directly on intes-
tinal epithelial cells. fMLF, but not other formylpeptides,
has been found to stimulate HSP27 in a human colonocyte
line, and HSP27 in turn blocks changes in transepithelial
electrical resistance and NF-jB activation stimulated by
other exogenous mediators [28]. These phenomena were
shown to be dependent on the peptide transporter, PepT1,
and not on any formyl peptide receptor, although a role for
the FPR1 was not ruled out. Thus, HSP27 stimulated by
fMLF provides cytoprotective mechanisms. Should the
FPR1 be related to this action of a formlypeptide in the
mouse, then the cytoprotective effect would be lost in
the receptor-deﬁcient mice, possibly explaining the greater
epithelial damage in the mice. This mechanism is compati-
ble with a number of bacterial sensing receptors directly
providing intestinal epithelial protective processes. Until
experiments are planned to pursue this outcome in the
FPR1
-/- mice, the data here answer the question of whether
the FPR1 mediates neutrophil inﬁltration of the colonic
mucosa, and FPR1 is dispensable for this migration.
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